We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
Neutralizing antibodies, whether pre-existing or developed, are a massive barrier to large populations of patients. The partnership opens a new door to genetic treatments; TACs allow for increased patient access and repeat treatment, which enables a full and durable benefit from the therapy.